Anika Finze
Overview
Explore the profile of Anika Finze including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
161
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zatcepin A, Gnorich J, Rauchmann B, Bartos L, Wagner S, Franzmeier N, et al.
Mol Neurodegener
. 2024 Sep;
19(1):64.
PMID: 39238030
Background: Microglial activation is one hallmark of Alzheimer disease (AD) neuropathology but the impact of the regional interplay of microglia cells in the brain is poorly understood. We hypothesized that...
2.
Ferschmann C, Messerschmidt K, Gnorich J, Barthel H, Marek K, Palleis C, et al.
Eur J Nucl Med Mol Imaging
. 2024 Feb;
51(7):1909-1922.
PMID: 38366196
Purpose: We hypothesized that severe tau burden in brain regions involved in direct or indirect pathways of the basal ganglia correlate with more severe striatal dopamine deficiency in four-repeat (4R)...
3.
Biechele G, Rauchmann B, Janowitz D, Buerger K, Franzmeier N, Weidinger E, et al.
J Neuroinflammation
. 2024 Jan;
21(1):30.
PMID: 38263017
Background And Objectives: 18-kDa translocator protein position-emission-tomography (TSPO-PET) imaging emerged for in vivo assessment of neuroinflammation in Alzheimer's disease (AD) research. Sex and obesity effects on TSPO-PET binding have been...
4.
Palleis C, Franzmeier N, Weidinger E, Bernhardt A, Katzdobler S, Wall S, et al.
Neurology
. 2024 Jan;
102(1):e207901.
PMID: 38165362
Background And Objectives: Corticobasal syndrome (CBS) with underlying 4-repeat tauopathy is a progressive neurodegenerative disease characterized by declining cognitive and motor functions. Biomarkers for assessing pathologic brain changes in CBS...
5.
Finze A, Biechele G, Rauchmann B, Franzmeier N, Palleis C, Katzdobler S, et al.
Mol Psychiatry
. 2023 Jul;
28(10):4438-4450.
PMID: 37495886
β-amyloid (Aβ) and tau aggregation as well as neuronal injury and atrophy (ATN) are the major hallmarks of Alzheimer's disease (AD), and biomarkers for these hallmarks have been linked to...
6.
Schonecker S, Palleis C, Franzmeier N, Katzdobler S, Ferschmann C, Schuster S, et al.
Neuroimage Clin
. 2023 Apr;
38:103402.
PMID: 37087820
In recent years in vivo visualization of tau deposits has become possible with various PET radiotracers. The tau tracer [F]PI-2620 proved high affinity both to 3-repeat/4-repeat tau in Alzheimer's disease...
7.
Rauchmann B, Brendel M, Franzmeier N, Trappmann L, Zaganjori M, Ersoezlue E, et al.
Ann Neurol
. 2022 Sep;
92(5):768-781.
PMID: 36053756
Objective: Alzheimer disease (AD) is characterized by amyloid β (Aβ) plaques and neurofibrillary tau tangles, but increasing evidence suggests that neuroinflammation also plays a key role, driven by the activation...
8.
Franzmeier N, Brendel M, Beyer L, Slemann L, Kovacs G, Arzberger T, et al.
Nat Commun
. 2022 Mar;
13(1):1362.
PMID: 35292638
Tau pathology is the main driver of neuronal dysfunction in 4-repeat tauopathies, including cortico-basal degeneration and progressive supranuclear palsy. Tau is assumed to spread prion-like across connected neurons, but the...
9.
Finze A, Wahl H, Janowitz D, Buerger K, Linn J, Rominger A, et al.
Front Aging Neurosci
. 2022 Feb;
13:786143.
PMID: 35185518
Objective: This is a cross-sectional study to evaluate whether β-amyloid-(Aβ)-PET positivity and cortical superficial siderosis (cSS) in patients with cerebral amyloid angiopathy (CAA) are regionally colocalized. Methods: Ten patients with...
10.
Song M, Scheifele M, Barthel H, van Eimeren T, Beyer L, Marek K, et al.
Eur J Nucl Med Mol Imaging
. 2021 May;
48(12):3872-3885.
PMID: 34021393
Purpose: Dynamic 60-min positron emission tomography (PET) imaging with the novel tau radiotracer [F]PI-2620 facilitated accurate discrimination between patients with progressive supranuclear palsy (PSP) and healthy controls (HCs). This study...